444 related articles for article (PubMed ID: 32374043)
41. Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells.
Koch C; Fischer NC; Puchert M; Engele J
BMC Cancer; 2022 Dec; 22(1):1335. PubMed ID: 36539774
[TBL] [Abstract][Full Text] [Related]
42. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
Singh AK; Arya RK; Trivedi AK; Sanyal S; Baral R; Dormond O; Briscoe DM; Datta D
Cytokine Growth Factor Rev; 2013 Feb; 24(1):41-9. PubMed ID: 22989616
[TBL] [Abstract][Full Text] [Related]
43. Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked.
Koch C; Engele J
Mol Pharmacol; 2020 Nov; 98(5):577-585. PubMed ID: 32883765
[TBL] [Abstract][Full Text] [Related]
44. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
45. AMD3100 is a CXCR7 ligand with allosteric agonist properties.
Kalatskaya I; Berchiche YA; Gravel S; Limberg BJ; Rosenbaum JS; Heveker N
Mol Pharmacol; 2009 May; 75(5):1240-7. PubMed ID: 19255243
[TBL] [Abstract][Full Text] [Related]
46. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands.
Luker KE; Steele JM; Mihalko LA; Ray P; Luker GD
Oncogene; 2010 Aug; 29(32):4599-610. PubMed ID: 20531309
[TBL] [Abstract][Full Text] [Related]
47. Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.
Stephens BS; Ngo T; Kufareva I; Handel TM
Sci Signal; 2020 Jul; 13(640):. PubMed ID: 32665413
[TBL] [Abstract][Full Text] [Related]
48. Modulators of CXCR4 and CXCR7/ACKR3 Function.
Adlere I; Caspar B; Arimont M; Dekkers S; Visser K; Stuijt J; de Graaf C; Stocks M; Kellam B; Briddon S; Wijtmans M; de Esch I; Hill S; Leurs R
Mol Pharmacol; 2019 Dec; 96(6):737-752. PubMed ID: 31548340
[TBL] [Abstract][Full Text] [Related]
49. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status.
Fumagalli A; Zarca A; Neves M; Caspar B; Hill SJ; Mayor F; Smit MJ; Marin P
Mol Pharmacol; 2019 Dec; 96(6):794-808. PubMed ID: 30837297
[TBL] [Abstract][Full Text] [Related]
50. Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3.
Heuninck J; Perpiñá Viciano C; Işbilir A; Caspar B; Capoferri D; Briddon SJ; Durroux T; Hill SJ; Lohse MJ; Milligan G; Pin JP; Hoffmann C
Mol Pharmacol; 2019 Dec; 96(6):778-793. PubMed ID: 31092552
[TBL] [Abstract][Full Text] [Related]
51. Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.
Struyf S; Noppen S; Loos T; Mortier A; Gouwy M; Verbeke H; Huskens D; Luangsay S; Parmentier M; Geboes K; Schols D; Van Damme J; Proost P
J Immunol; 2009 Jan; 182(1):666-74. PubMed ID: 19109200
[TBL] [Abstract][Full Text] [Related]
52. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
Szpakowska M; Dupuis N; Baragli A; Counson M; Hanson J; Piette J; Chevigné A
Biochem Pharmacol; 2016 Aug; 114():14-21. PubMed ID: 27238288
[TBL] [Abstract][Full Text] [Related]
53. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
54. ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 production.
Antonello P; Pizzagalli DU; Foglierini M; Melgrati S; Radice E; Thelen S; Thelen M
Front Immunol; 2022; 13():1067885. PubMed ID: 36713377
[TBL] [Abstract][Full Text] [Related]
55. Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.
Quinn KE; Mackie DI; Caron KM
Cytokine; 2018 Sep; 109():17-23. PubMed ID: 29903572
[TBL] [Abstract][Full Text] [Related]
56. Decreased ACKR3 (CXCR7) function causes oculomotor synkinesis in mice and humans.
Whitman MC; Miyake N; Nguyen EH; Bell JL; Matos Ruiz PM; Chan WM; Di Gioia SA; Mukherjee N; Barry BJ; Bosley TM; Khan AO; Engle EC
Hum Mol Genet; 2019 Sep; 28(18):3113-3125. PubMed ID: 31211835
[TBL] [Abstract][Full Text] [Related]
57. Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells.
Neves M; Marolda V; Mayor F; Penela P
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233192
[TBL] [Abstract][Full Text] [Related]
58. Mode of binding of the cyclic agonist peptide TC14012 to CXCR7: identification of receptor and compound determinants.
Montpas N; Cabana J; St-Onge G; Gravel S; Morin G; Kuroyanagi T; Lavigne P; Fujii N; Oishi S; Heveker N
Biochemistry; 2015 Feb; 54(7):1505-15. PubMed ID: 25669416
[TBL] [Abstract][Full Text] [Related]
59. CXCR7 prevents excessive CXCL12-mediated downregulation of CXCR4 in migrating cortical interneurons.
Abe P; Mueller W; Schütz D; MacKay F; Thelen M; Zhang P; Stumm R
Development; 2014 May; 141(9):1857-63. PubMed ID: 24718993
[TBL] [Abstract][Full Text] [Related]
60. Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model.
Van Loy T; De Jonghe S; Castermans K; Dheedene W; Stoop R; Verschuren L; Versele M; Chaltin P; Luttun A; Schols D
Cell Mol Life Sci; 2022 May; 79(6):293. PubMed ID: 35562519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
